Profil
Andrew Muratore currently works at Trillium Therapeutics ULC, as Director & Vice President from 2021.
Postes actifs de Andrew Muratore
| Sociétés | Poste | Début |
|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 17/11/2021 |
Expériences
Fonctions occupées
Relations
16
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
